The relationship between fibrinogen levels after cardiopulmonary bypass and large volume red cell transfusion in cardiac surgery: an observational study K Karkouti, J Callum, MA Crowther, SA McCluskey, J Pendergrast, G Tait, ... Anesthesia & Analgesia 117 (1), 14-22, 2013 | 127 | 2013 |
A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload L Lieberman, C Maskens, C Cserti-Gazdewich, M Hansen, Y Lin, ... Transfusion medicine reviews 27 (4), 206-212, 2013 | 124 | 2013 |
Proceedings of a consensus conference: pathogen inactivation—making decisions about new technologies KE Webert, CM Cserti, J Hannon, Y Lin, K Pavenski, JM Pendergrast, ... Transfusion Medicine Reviews 22 (1), 1-34, 2008 | 118 | 2008 |
Bloody Easy 4: blood transfusions, blood alternatives and transfusion reactions: a guide to transfusion medicine JL Callum, PH Pinkerton, A Lima, Y Lin, K Karbouti, L Lieberman, ... ORBCoN, Ontario Regional Blood Coordinating Network, 2016 | 83 | 2016 |
Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia CJ Patriquin, V Laroche, R Selby, J Pendergrast, D Barth, B Côté, ... New England Journal of Medicine 385 (9), 857-859, 2021 | 82 | 2021 |
Platelet dysfunction as measured by a point-of-care monitor is an independent predictor of high blood loss in cardiac surgery D Orlov, SA McCluskey, R Selby, P Yip, J Pendergrast, K Karkouti Anesthesia & Analgesia 118 (2), 257-263, 2014 | 49 | 2014 |
Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions R Cohen, A Escorcia, F Tasmin, A Lima, Y Lin, L Lieberman, ... Transfusion 57 (7), 1674-1683, 2017 | 44 | 2017 |
The association of fever with transfusion‐associated circulatory overload N Parmar, J Pendergrast, L Lieberman, Y Lin, J Callum, ... Vox Sanguinis 112 (1), 70-78, 2017 | 42 | 2017 |
Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of … CM Cserti-Gazdewich, TK Waddell, LG Singer, C Chaparro, ... Transfusion medicine reviews 23 (2), 134-145, 2009 | 41 | 2009 |
Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995–2000 JM Pendergrast, GD Sher, JL Callum Vox sanguinis 89 (3), 150-160, 2005 | 41 | 2005 |
Evaluating appropriate red blood cell transfusions: a quality audit at 10 Ontario hospitals to determine the optimal measure for assessing appropriateness J Spradbrow, R Cohen, Y Lin, C Armali, A Collins, C Cserti‐Gazdewich, ... Transfusion 56 (10), 2466-2476, 2016 | 40 | 2016 |
Seek and you shall find—but then what do you do? Cold agglutinins in cardiopulmonary bypass and a single-center experience with cold agglutinin screening before cardiac surgery MD Jain, R Cabrerizo-Sanchez, K Karkouti, T Yau, JM Pendergrast, ... Transfusion medicine reviews 27 (2), 65-73, 2013 | 40 | 2013 |
Acute hemolysis after intravenous immunoglobulin amid host factors of ABO‐mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes FV Michelis, DR Branch, I Scovell, E Bloch, J Pendergrast, JH Lipton, ... Transfusion 54 (3), 681-690, 2014 | 38 | 2014 |
A regional massive hemorrhage protocol developed through a modified Delphi technique JL Callum, CH Yeh, A Petrosoniak, MJ McVey, S Cope, T Thompson, ... Canadian Medical Association Open Access Journal 7 (3), E546-E561, 2019 | 34 | 2019 |
The role of inflammation in intravenous immune globulin–mediated hemolysis J Pendergrast, K Willie‐Ramharack, L Sampson, V Laroche, DR Branch Transfusion 55 (S2), S65-S73, 2015 | 34 | 2015 |
Optimal conditions for the performance of a monocyte monolayer assay TN Tong, E Burke‐Murphy, D Sakac, J Pendergrast, C Cserti‐Gazdewich, ... Transfusion 56 (11), 2680-2690, 2016 | 31 | 2016 |
Impact of red blood cell alloimmunization on fetal and neonatal outcomes: a single center cohort study L Lieberman, J Callum, R Cohen, C Cserti‐Gazdewich, NNN Ladhani, ... Transfusion 60 (11), 2537-2546, 2020 | 26 | 2020 |
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis DR Branch, Å Hellberg, CW Bruggeman, JR Storry, D Sakac, ... Blood, The Journal of the American Society of Hematology 131 (7), 830-835, 2018 | 23 | 2018 |
Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees Y Lin, E Tilokee, S Chargé, A Alam, C Cserti‐Gazdewich, W Lau, C Lee, ... Transfusion 59 (6), 2141-2149, 2019 | 22 | 2019 |
Audit of appropriate use of platelet transfusions: validation of adjudication criteria M Etchells, J Spradbrow, R Cohen, Y Lin, C Armali, L Lieberman, ... Vox Sanguinis 113 (1), 40-50, 2018 | 21 | 2018 |